Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 4107-4110

  Ergen, H Arzu ^a   Gormus, Uzay ^a   Narter, Fehmi ^b   Zeybek, Umit ^a   Bulgurcuoglu, Sibel ^a   Isbir, Turgay ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Uskudar State Hospital   (Turkey)

Author keywords

NAD(P)H:quinone oxidoreductase 1; NQO1; Polymorphism; Prostate cancer; Reactive oxygen species; Serum PSA levels

Indexed keywords

OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLELE; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENOTYPE; HUMAN; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR VOLUME;

AGED; ALKALINE PHOSPHATASE; ALLELES; BODY MASS INDEX; CREATININE; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TURKEY;

EID: 37549040507     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chen H, Lum A, Seifried A, Wilkens LR and Le Marchand L: Association of the NAD(P)H:Quinone oxidoreductase 609CT polymorphism with a decreased lung cancer risk. Cancer Research 59: 3045-3048, 1999.
2. Hou L, Chatterjee N, Huang W, Baccarelli A, Yadavalli S, Yeager M, Bresalier RS, Chanock SJ, Caporaso NE, Ji B, Weissfeld JL and Hayes RB: CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use and risk for colorectal adenoma. Carcinogenesis 26(6): 1122-1128, 2005.
3. Sarmanova J, Susova S, Gut I, Mrhalova M, Kodet R, Adamek J, Roth Z and Soucek P: Breast cancer: role of polymorphisms in biotransformation enzymes. Eur J Hum Gen 12: 848-854, 2004.
4. Jones SB and Brooks JD: Modest induction of phase 2 enzyme activity in the F-344 rat prostate. BMC Cancer 6(62): 1-9, 2006.
5. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho S, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters DJ and Timms B: Human prostate cancer risk factors. Cancer 101(10): 2371-2490, 2004.
6. Hamajima N, Matsuo K, Iwata H, Shinoda M, Yamamura Y, Kato T, Hatooka S, Mitsudomi T, Suyama M, Kagami Y, Ogura M, Ando M, Sugimura Y and Tajima K: NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T Polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol 7(2): 103-108, 2002.
7. Fong CS, Wu RM, Shieh JC, Chao YT, Fu YP, Kuao CL and Cheng CW: Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease. Clin Chim Acta 378: 136-141, 2007.
8. Miller SA, Dykes DD and Polesky HS: Simples salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Research 16: 1215-1219, 1988.
9. Olson SH, Carlson MDA, Ostrer H, Harlap S, Stone A, Winters M and Amrosone CB: Genetic variants in SOD2, MPO and NQO1 and risk of ovarian cancer. Gynecol Oncol 93: 615-620, 2004.
10. Halliwell B: Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 44(8924): 721-724, 1994.
11. Fleshner NE and Klotz LH: Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev 17(4): 325-330, 1999.
12. Mitrou PN, Watson MA, Loktionov AS, Cardwell C, Gunter MJ, Atkin WS, Macklin CP, Cecil T, Bishop DT, Primrose J and Bingham SA: Role of NQO1 C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study. Carcinogenesis 28(4): 875-882, 2007.
13. Traver RD, Horikoshi T, Danenberg KD, Stadlbauer TH, Danenberg PV, Ross D and Gibson NW: NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 52(4): 797-802, 1992.
14. Siegel D, McGuinness SM, Winski SL and Ross D: Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics 9(1): 113-121, 1999.
15. Goldstein NS: Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol 117: 471-477, 2002.